Annual Securities Report — FY2025
What PHC Holdings Corporation reported for the period from 2025-04-01 to 2026-03-31.
Filed 2026-06-23View the original on EDINET
How much it says
57Typical
What moved here
52named for the first time
Its own wording
81terms
Which filing this is
13/ 13newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the fiscal year ended 31 March 2026, revenue increased, while profit before tax declined partly due to foreign exchange and other factors. On the business front, the Group entered into an agreement to transfer the Eversense continuous glucose monitoring sales business, completed the transfer in the United States, and proceeded with a review of its R&D structure and the launch of new products.
Komori's summary of this document, not the document's own words.57Typical
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 37 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
76
Very detailed
68
Detailed
100
Very detailed
62
Detailed
0
Almost nothing
50
Typical
41
Thin
55
Typical
60
Detailed
55
Typical
50
Typical
R&D spend109億円Money spent making new things.
Cash left over334億円Cash from the business, less what went into equipment.
Spent on equipment91億円Plants, machines — things meant to last.
Employees8,647Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.